Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

PLAC1L Inhibitors

PLAC1L inhibitors represent a class of chemical compounds designed to target and inhibit the activity of the PLAC1L protein, a specific member of the placenta-specific family of proteins. PLAC1L is encoded by a gene located on the X chromosome and is thought to play a role in various cellular processes related to placental and embryonic development. The inhibitors of PLAC1L are crafted with precision to interact with the active or binding sites of this protein, disrupting its function and the downstream signaling pathways it may influence. Structurally, PLAC1L inhibitors often contain specific chemical moieties that enable them to bind selectively to PLAC1L, preventing its normal biological interactions, thus halting its ability to contribute to specific cellular pathways. These inhibitors are usually small molecules with finely tuned physicochemical properties, such as optimized lipophilicity, solubility, and molecular weight, allowing for precise targeting and modulation of PLAC1L-related biological functions.

From a chemical standpoint, PLAC1L inhibitors undergo extensive development involving techniques like high-throughput screening, molecular docking studies, and structure-activity relationship (SAR) analyses. Such approaches allow chemists to identify lead compounds with the highest affinity for PLAC1L. Once promising leads are identified, they are subjected to optimization, where their chemical structures are adjusted to enhance their binding specificity, reduce off-target effects, and improve their overall stability. Common strategies in the development of PLAC1L inhibitors include the use of heterocyclic frameworks and aromatic rings, which facilitate strong interactions with the target protein. Additionally, the inhibitors are often designed to avoid rapid metabolic degradation, increasing their persistence within cellular environments. These efforts ensure that the inhibitors can reliably block PLAC1L function, allowing scientists to further explore the protein's role in cellular processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

May disrupt DNA methylation patterns, potentially leading to the silencing of PLAC1L gene transcription.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Could enhance histone acetylation, resulting in the chromatin remodeling necessary to repress PLAC1L gene expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Might induce hyperacetylation of histones associated with the PLAC1L gene, leading to a condensed chromatin state and reduced transcription.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Has the potential to repress PLAC1L expression by altering retinoid-responsive cellular pathways and transcription factor binding.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Could lead to a depletion of nucleotide pools, thereby hindering the synthesis of the PLAC1L mRNA transcript.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

May decrease PLAC1L expression by inhibiting mTOR signaling, which is often associated with the control of protein synthesis.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Possesses the potential to downregulate PLAC1L expression by interfering with specific signal transduction pathways linked to cell growth and survival.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$150.00
$286.00
$479.00
$1299.00
$8299.00
$915.00
22
(1)

May attenuate PLAC1L mRNA levels by activating detoxification pathways that lead to the repression of certain oncogenes.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Could suppress the transcription of PLAC1L through attenuation of NF-κB signaling, which is implicated in the control of numerous genes.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$52.00
$87.00
7
(1)

Might inhibit the degradation of regulatory proteins that suppress PLAC1L gene transcription, resulting in decreased PLAC1L expression.